A Day in the Life of a Cannabis Nurse
Dawn-Marie Steentra, LPN guides us through a day in the life of a Cannabis Nurse. The work requires ongoing compassion, education, and enthusiasm for patient advocacy.
This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
A history of the Society of Cannabis Clinicians and its contributions and impact on the US medical cannabis movement
Dr. Kevin M.Takakuwa details the history of the SCC, which is the first and oldest U.S. medical organization promoting the use of medical cannabis.
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials.
Expert Opinion on Drug Metabolism & Toxicology, 9 April 2020
—
Introduction: Recent trials using cannabidiol (CBD) have shown that most acute and prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects (SAEs). This review focused on analyzing SAEs of CBD and their possible relation to drug-drug interaction…
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.
Neuropsychopharmacology, 8 April 2020
—
Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety. We conducted the first systematic review and meta-analysis of the adverse effects of CBD across all medical indications. Double-blind randomized plac…
Patients’ Rights Jeopardized in California
Bobby Eisenberg has worked with El Dorado officials to develop regulations that recognize a patient’s right to grow as much cannabis as their doctor authorizes. Now the planning commission in El Dorado Country wants to impose a six-plant limit.
Examining Medical Cannabis Models Worldwide: Access Amidst Lockdown
What would we envision as the best cannabis model for international patient access? This question was explored at a collaborative event in Barcelona just before the COVID-19 lockdowns swept over Spain (and the world).
Cannabis & The COVID-19 Pandemic: A Physician’s Perspective
Joe D. Goldstrich, MD, FACC outlines what we know about the antiviral properties of cannabis and whether or not it could be helpful or detrimental for COVID-19.
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
Frontiers in Pharmacology, 25 March 2020
—
The entourage effect was a proposed explanation for biological observations that endocannabinoid ligand activities can be modified by other lipids released from cells at the same time. An increasing volume of anecdotal reports and interest in the plant have provoked research i…
Sex, Intimacy, and Cannabis
Sarah Mann, MD separates myth and conjecture from what is known (and unknown) about cannabis and sex.
Labeling of Cannabidiol Products: A Public Health Perspective
Cannabis and Cannabinoid Research, 6 March 2020
—
Introduction: Interest in the therapeutic use of cannabidiol (CBD) has reached a fever-pitch in recent months, as CBD-containing products appear everywhere from online retailers to grocery stores and gas stations. The widespread availability of hemp-derived CBD products is con…
The Endocannabinoid System of Animals
This review paper by Dr. Robert Silver gives an overview of the ECS in animals and highlights it as a topic of interest for emerging therapeutics.
Cannabis education needs assessment among Canadian physicians-in-training.
Canadian researchers found that the average training from physicians in training was 25% less than what they desired and that further training was paramount for them to engage in cannabis for therapeutic purposes (2020).